Legend Biotech (LEGN) Tops Q4 EPS by 9c

Legend Biotech (NASDAQ: LEGN) reported Q4 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $186.52 million versus the consensus estimate of $173.99 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• Apple investigating exposure to Tata Electronics data breach, full analysis underway - Reuters
• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
• SpaceX signs compute deal with Reflection - CNBC